Intech Biopharm Corporation (6461)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
15. 90
-0.05
-0.3135%
NT$
- Market Cap
- P/E Ratio
- Div Yield
115,833 Volume
- Eps
NT$ 15.95
Previous Close Want to track 6461 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 6461 split of 309:500 in 22 days (2 Sep 2026)
Summary
6461 closed today lower at NT$15.9, a decrease of -0.3135% from yesterday's close, completing a monthly increase of 4.6053% or NT$0.7. Over the past 12 months, 6461 stock lost -18.6701%.
6461 is not paying dividends to its shareholders.
Intech Biopharm Corporation has a scheduled stock split on Sep 02, 2026 for a 309:500 split ratio, meaning every 6461 investor will receive 309.0 shares for every 500.0 existing shares.
Intech Biopharm Corporation has completed 3 stock splits, with the recent split occurring on Sep 26, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).
6461 Chart
Intech Biopharm Corporation (6461) FAQ
What is the stock price today?
The current price is NT$15.90.
On which exchange is it traded?
Intech Biopharm Corporation is listed on TWSE.
What is its stock symbol?
The ticker symbol is 6461.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Intech Biopharm Corporation ever had a stock split?
Intech Biopharm Corporation had 3 splits and the recent split was on Sep 26, 2023.
